Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06761404 · ClinicalTrials.gov registry record · NA

Non-invasive VNS in Stroke Recovery

A NA study of Stroke, sponsored by The Methodist Hospital Research Institute.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06761404: Recruiting NA study of Stroke, sponsored by The Methodist Hospital Research Institute.

NCT06761404 is a NA study of Stroke that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 60 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06761404, a NA study of Stroke, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

To evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery

Primary Outcome

To determine the extent to which taVNS with concurrent occupational therapy (OT), causes significant, lasting motor gains in chronic stroke population Upper extremity Fugl-Meyer (uFM) The uFM test measures both proximal and distal upper extremity movements, ranges 0-66, higher score is better.

Conditions Studied

Interventions

  • DEVICE taVNS

Study Locations (1)

Texas

  • Houston Methodist Research Institute - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-04-15
Est. Completion 2028-06-01
Phase NA

What NCT06761404 shows while recruiting

NCT06761404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which taVNS is the first listed.

NCT06761404 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06761404 about?

NCT06761404 is a clinical study titled "Non-invasive VNS in Stroke Recovery". To evaluate feasibility and effectiveness of non-invasive VNS to enhance stroke recovery

What is the current status of trial NCT06761404?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-04-15. Estimated completion is 2028-06-01.

What conditions does trial NCT06761404 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06761404?

The interventions under investigation include: taVNS (DEVICE).

Who is sponsoring clinical trial NCT06761404?

This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06761404 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06761404's enrollment target sits among peer trials

60 206th of 454 higher than 236 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06761404, the US trial registry maintained by the National Library of Medicine. NCT06761404 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.